Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia.

Author:

Franks S,Horrocks P M,Lynch S S,Butt W R,London D R

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference12 articles.

1. Pharmacologic effects in man of a potent long-acting dopamine receptor agonist;Lemberger, L.; Crabtree, R.E.;Science,1979

2. Clin Endocrinol Metab,1981

3. Twenty-four hour suppression of prolactin by pergolide mesylate lAbstract 679];Kleinberg, D.L.; Lieberman, A.; Todd, J.; Meddick, J.; Neophytides, A.; Kuppersmith, M.,1980

4. Maryland: Endocrine;Bethesda;Society

5. Treatment of hyperprolactinaemia with pergolide mesylate: acute effects and preliminary evaluation of long-term treatment;Lancet,1981

Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Prolactinom-Behandlung mit einem neuen Dopaminagonisten;DMW - Deutsche Medizinische Wochenschrift;2008-03-25

2. Current treatment issues in female hyperprolactinaemia;European Journal of Obstetrics & Gynecology and Reproductive Biology;2006-04

3. Hyperprolactinemia in Men: Clinical and Biochemical Features and Response to Treatment;Endocrine;2003

4. Hyperprolactinemia;Treatments in Endocrinology;2003

5. Long-term treatment of prolactin-secreting macroadenomas with pergolide;J CLIN ENDOCR METAB;2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3